semaglutide supply shortage news november 2025 glp-1 weight loss drug Weight-Loss Drugs Could Address a Range of Addictions GLP-1 Trends: Access & Shortages, – Novo Nordisk has halved the

Protecting heart health is an important goal

Previous studies of the weight-loss drug semaglutide hinted that people using either Ozempic or Wegovy had less troublesome alcohol cravings

Lifestyle strategies and medical treatment may help people manage some of the symptoms

You can start your intake for $0 today

Unlike GLP-1 or GIP analogs that target incretin receptors, Cagrilintide operates as a non-selective agonist of both the amylin receptor (AMYR) complexes and calcitonin receptors (CTR)

Health Canada announced Monday that it has authorized Svemia, a once-weekly semaglutide injection made by Canadian pharmaceutical company Apotex, for chronic weight management in people aged 12 and older as a supplement to a reduced-calorie diet and increased physical activity for chronic weight management. The approval marks the first generic semaglutide injection authorized in Canada for weight loss